HK1049160B - 1-氨基-烷基環已烷化合物nmda受體拮抗劑 - Google Patents
1-氨基-烷基環已烷化合物nmda受體拮抗劑Info
- Publication number
- HK1049160B HK1049160B HK03101158.3A HK03101158A HK1049160B HK 1049160 B HK1049160 B HK 1049160B HK 03101158 A HK03101158 A HK 03101158A HK 1049160 B HK1049160 B HK 1049160B
- Authority
- HK
- Hong Kong
- Prior art keywords
- amino
- nmda receptor
- compounds
- alleviation
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1999/008317 WO2001032640A1 (en) | 1999-11-01 | 1999-11-01 | 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1049160A1 HK1049160A1 (en) | 2003-05-02 |
HK1049160B true HK1049160B (zh) | 2006-11-17 |
Family
ID=8167482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03101158.3A HK1049160B (zh) | 1999-11-01 | 2003-02-18 | 1-氨基-烷基環已烷化合物nmda受體拮抗劑 |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1228052B1 (zh) |
JP (1) | JP4043236B2 (zh) |
KR (1) | KR100548600B1 (zh) |
CN (1) | CN1264827C (zh) |
AT (1) | ATE361284T1 (zh) |
AU (1) | AU782760B2 (zh) |
CA (1) | CA2389325C (zh) |
CY (1) | CY1106672T1 (zh) |
CZ (1) | CZ20021533A3 (zh) |
DE (1) | DE69936004T2 (zh) |
DK (1) | DK1228052T3 (zh) |
EA (1) | EA005684B1 (zh) |
ES (1) | ES2285870T3 (zh) |
HK (1) | HK1049160B (zh) |
HU (1) | HUP0203275A3 (zh) |
IL (2) | IL149401A0 (zh) |
MX (1) | MXPA02004368A (zh) |
NO (1) | NO322359B1 (zh) |
PL (1) | PL199587B1 (zh) |
PT (1) | PT1228052E (zh) |
SI (1) | SI1228052T1 (zh) |
TW (1) | TWI242547B (zh) |
UA (1) | UA72558C2 (zh) |
WO (1) | WO2001032640A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての3−ヒドロキシ−1,5−ジヒドロ−ピロール−2−オン誘導体 |
ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
NZ579310A (en) | 2007-03-01 | 2012-03-30 | Probiodrug Ag | Use of glutaminyl cyclase inhibitors for the treatment of mild cognitive impairment and diagnostic purposes thereof |
DK2142514T3 (da) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thioureaderivater som glutaminylcyclase-inhibitorer |
US8486940B2 (en) | 2009-09-11 | 2013-07-16 | Probiodrug Ag | Inhibitors |
EP2542549B1 (en) | 2010-03-03 | 2016-05-11 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
BR112012022478B1 (pt) | 2010-03-10 | 2021-09-21 | Probiodrug Ag | Inibidores heterocíclicos de glutaminil ciclase (qc, ec 2.3.2.5), seu processo de preparação, e composição farmacêutica |
US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
CN104211663B (zh) * | 2014-08-11 | 2017-01-11 | 杭州偶联医药科技有限公司 | 一种(s)-n-甲氧基-甲基-2-(四氢吡咯基)丙酰胺及其制备方法和应用 |
ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
RU2714135C1 (ru) * | 2019-11-22 | 2020-02-12 | Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" | Гидрохлорид (1-метилпиперидин-4-ил)-2-пропилпентаноата, обладающий холинолитической и противосудорожной активностью |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3097207A (en) * | 1958-03-06 | 1963-07-09 | Parke Davis & Co | 1-halophenyl and 1-alkoxyphenyl cyclohexylamines |
PT1009732E (pt) * | 1997-06-30 | 2003-10-31 | Merz & Co Gmbh & Co | 1-amino-alquilciclo-hexanos antagonistas do receptor nmda |
-
1999
- 1999-01-11 UA UA2002054475A patent/UA72558C2/uk unknown
- 1999-11-01 KR KR1020027005621A patent/KR100548600B1/ko not_active IP Right Cessation
- 1999-11-01 IL IL14940199A patent/IL149401A0/xx active IP Right Grant
- 1999-11-01 MX MXPA02004368A patent/MXPA02004368A/es not_active IP Right Cessation
- 1999-11-01 PT PT99974146T patent/PT1228052E/pt unknown
- 1999-11-01 EP EP99974146A patent/EP1228052B1/en not_active Expired - Lifetime
- 1999-11-01 AT AT99974146T patent/ATE361284T1/de not_active IP Right Cessation
- 1999-11-01 JP JP2001534791A patent/JP4043236B2/ja not_active Expired - Fee Related
- 1999-11-01 ES ES99974146T patent/ES2285870T3/es not_active Expired - Lifetime
- 1999-11-01 DK DK99974146T patent/DK1228052T3/da active
- 1999-11-01 SI SI9930972T patent/SI1228052T1/sl unknown
- 1999-11-01 DE DE69936004T patent/DE69936004T2/de not_active Expired - Fee Related
- 1999-11-01 CZ CZ20021533A patent/CZ20021533A3/cs unknown
- 1999-11-01 EA EA200200522A patent/EA005684B1/ru not_active IP Right Cessation
- 1999-11-01 WO PCT/EP1999/008317 patent/WO2001032640A1/en active IP Right Grant
- 1999-11-01 HU HU0203275A patent/HUP0203275A3/hu unknown
- 1999-11-01 PL PL354519A patent/PL199587B1/pl not_active IP Right Cessation
- 1999-11-01 CN CNB998169900A patent/CN1264827C/zh not_active Expired - Fee Related
- 1999-11-01 AU AU11585/00A patent/AU782760B2/en not_active Ceased
- 1999-11-01 CA CA002389325A patent/CA2389325C/en not_active Expired - Fee Related
- 1999-11-15 TW TW088119884A patent/TWI242547B/zh not_active IP Right Cessation
-
2002
- 2002-04-29 IL IL149401A patent/IL149401A/en not_active IP Right Cessation
- 2002-04-30 NO NO20022044A patent/NO322359B1/no not_active IP Right Cessation
-
2003
- 2003-02-18 HK HK03101158.3A patent/HK1049160B/zh not_active IP Right Cessation
-
2007
- 2007-06-21 CY CY20071100831T patent/CY1106672T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1049160A1 (en) | 1-Amino-alkylcyclohexane compound nmda receptor antagonist | |
HUT56368A (en) | Process for producing tricyclic compounds and pharmaceutical compositions comprising such compounds | |
EP1361220A4 (en) | CYCLIC COMPOUNDS WITH THROMBOPOIETIN RECEPTAGONISM | |
KR20050085991A (en) | Compounds exhibiting thrombopoietin receptor agonism | |
DE69831868D1 (en) | Antithrombosemittel | |
WO2005058884A3 (en) | Cyclopropane compounds and pharmaceutical use thereof | |
CA2344290A1 (en) | Quinazoline derivatives | |
IL124537A0 (en) | Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same | |
IL119729A0 (en) | Heterocyclic compounds having tachykinin receptor antagonist activity pharmaceutical compositions containing the same and processes for the preparation thereof | |
AU2337197A (en) | Cinnamic acid derivatives and their use as integrin antagonists | |
CA2360360A1 (en) | Piperidyl benzamide compounds, composition containing same and their use thereof | |
AU2267495A (en) | Benzamide derivatives as vasopressin antagonists | |
HK1052697A1 (en) | Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same. | |
IL125982A0 (en) | 2-(arylphenyl) amino-imidazoline derivatives | |
MX2023001725A (es) | Derivados de espiropiperidinilo sustituidos con heteroarilo y usos farmaceuticos de los mismos. | |
IL108970A0 (en) | Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them | |
HUT60491A (en) | Process for producing substituted n-benzylindole derivatives having leukotriene antagonist effect and pharmaceutical compositions comprising such compounds | |
HUT61018A (en) | Process for producing 3-/1-thiazolidinylbutyl-4-piperazinyl/1-h-indazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
CR20230218A (es) | Nuevos derivados de indazol acetileno | |
EP1559707A4 (en) | SPIRO COMPOUNDS, MEDICINAL COMPOSITIONS CONTAINING THE SAID COMPOUNDS AND INTERMEDIATES THEREOF | |
WO2005049559A3 (en) | Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3) | |
CA2335394A1 (en) | Aerothricin analogs, their preparation and use | |
KR930703275A (ko) | 벤조옥사디논유도체 | |
AR023701A1 (es) | Compuestos de 1-cicloamin-alquilciclohexano, composiciones farmaceuticas de los mismos, metodo de tratamiento de las convulsiones y de preparacion de los compuestos, y su uso como anticonvulsivos | |
YU38498A (sh) | Derivati 2-(arilfenil)amino-imidazolina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20101101 |